Average Co-Inventor Count = 4.39
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Syntex (u.s.a.) Inc. (26 from 932 patents)
2. Roche Palo Alto LLC (15 from 322 patents)
3. Calithera Biosciences, Inc. (11 from 30 patents)
4. Roivant Sciences Gmbh (4 from 5 patents)
5. Other (2 from 832,843 patents)
6. Karos Pharmaceuticals, Inc. (2 from 3 patents)
7. Hoffmann-la Roche Inc. (1 from 4,945 patents)
8. Altavant Sciences Gmbh (1 from 8 patents)
9. Kanos Pharmaceuticals, Inc. (1 from 1 patent)
10. Precision Pharmaceuticals, Inc. (1 from 1 patent)
11. F. Hoffmann-la Roche Ag (168 patents)
64 patents:
1. 12054501 - Compositions and methods for inhibiting arginase activity
2. 11759462 - Spirocyclic compounds as tryptophan hydroxylase inhibitors
3. 11208414 - Ectonucleotidase inhibitors and methods of use thereof
4. 11021495 - Compositions and methods for inhibiting arginase activity
5. 10946018 - Spirocyclic compounds as tryptophan hydroxylase inhibitors
6. 10851118 - Compositions and methods for inhibiting arginase activity
7. 10844080 - Compositions and methods for inhibiting arginase activity
8. 10793535 - Heterocyclic glutaminase inhibitors
9. 10660893 - Spirocyclic compounds as tryptophan hydroxylase inhibitors
10. 10597411 - Compositions and methods for inhibiting arginase activity
11. 10472364 - Ectonucleotidase inhibitors and methods of use thereof
12. 10350208 - Spirocyclic compounds as tryptophan hydroxylase inhibitors
13. 10287303 - Compositions and methods for inhibiting arginase activity
14. 10065974 - Compositions and methods for inhibiting arginase activity
15. 10045988 - Spirocyclic compounds as tryptophan hydroxylase inhibitors